Low doses of silver make bacteria more susceptible to antibiotic attack, paving the way for new therapies for drug-resistant and recurrent infections
Slipping bacteria some silver could give old antibiotics new life, scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University reported June 19 in Science Translational Medicine.
Treating bacteria with a silver-containing compound boosted the efficacy of a broad range of widely used antibiotics and helped them stop otherwise lethal infections in mice. It helped make an antibiotic-resistant strain of bacteria sensitive to antibiotics again. And it expanded the power of an antibiotic called vancomycin that is usually only effective in killing pathogens called Gram-positive bacteria, such as Staph and Strep. Silver allowed vancomycin for the first time to penetrate and kill Gram-negative bacteria, a group that includes microbes that can cause food poisoning and dangerous hospital-acquired infections.
Silver also proved useful for two types of stubborn infections that usually require repeated rounds of antibiotic treatment and multiple visits to the clinic: dormant bacteria that lie low during antibiotic treatment and rebound to cause recurrent infections, and microbial slime layers called biofilms that coat catheters and prosthetic joints.
“The results suggest that silver could be incredibly valuable as an adjunct to existing antibiotic treatments,” said Jim Collins, Ph.D., a pioneer of synthetic biology and Core Faculty member at the Wyss Institute, who is also the William F. Warren Distinguished Professor at Boston University, where he leads the Center of Synthetic Biology.
In recent years more disease-causing bacteria have grown resistant to common antibiotics, with serious public health consequences. Yet drug companies have struggled for years to develop new types of antibiotics that target these tough bacteria. That has led scientists to re-examine older methods that were used to fight infection well before penicillin use took off in the 1940s. Silver treatment, which has been used since antiquity to prevent and heal infections, is one of them.
Despite silver’s long history of use in the clinic, no one understood fully how it killed bacteria.To find out, Ruben Morones-Ramirez, Ph.D., a postdoctoral fellow at the Wyss Institute who left recently to become a professor at Universidad Autònoma de Nuevo Leon in Mexico, treated normal and mutant strains of E. coli bacteria with a silver compound. Then he observed them under the electron microscope and ran a series of biochemical tests.
He found that silver compounds cause bacteria to produce more reactive oxygen species – chemically reactive molecules that damage the bacterial cell’s DNA and enzymes, as well as the membrane that encloses the cell. Silver also made the bacteria’s cell membrane leakier.
Although silver was used alone as a therapy in the past, the scientists suspected that both changes might make cells more vulnerable to conventional antibiotics — and they did. A small amount of silver made E. coli bacteria between 10 and 1000 times more sensitive to three commonly used antibiotics: gentamycin, ofloxacin, and ampicillin.
“If you know the mechanism, you can have much more success making combinatorial therapies,” Morones-Ramirez said.
In mice, silver also helped antibiotics fight E. coli-induced urinary-tract infections. It made a previously impervious strain of E. coli sensitive to the antibiotic tetracycline. And it allowed vancomycin to save the lives of 90 percent of mice with life-threatening cases of peritonitis — inflammation caused by infections of the abdominal space surrounding the internal organs. Without silver, only 10 percent of the mice survived.
The scientists also did a series of toxicity studies, showing that the doses of silver needed to help antibiotics kill bacteria were far below what could harm the mice. Nor did they harm cultured human cells, suggesting that oral and injectable silver could be safe for humans as well.
The Latest Bing News on:
Drug-resistant and recurrent infections
- A synthetic antibiotic may help turn the tide against drug-resistant pathogenson May 26, 2022 at 12:11 pm
A synthesized antibiotic derived from computer models of bacterial gene products appears to neutralize even drug-resistant bacteria. The compound, named cilagicin, works well in mice and employs a ...
- Antiviral Drug Resistance Market Exceed US$ 4,573.24 million in 2027 says, The Insight Partnerson May 26, 2022 at 4:30 am
According to The Insight Partners market research study titled ‘Antiviral Drug Resistance Market to 2027 – Global ... It is a major global health problem that can cause chronic infection and also ...
- How Nanotechnology Can Help Address Multidrug Resistance?on May 26, 2022 at 1:47 am
Nanotechnology is also demanding more attention as a possible solution to the problem of MDR bacteria. Learn more about how nanotechnology can help address multidrug resistance here.
- Can drug resistant TB be reversed with a novel small molecule? Scientists turn to an animal model to find outon May 24, 2022 at 10:38 am
Tuberculosis is a major public health concern, an ancient bacterial disease that has claimed the lives of kings, presidents, poets and at least one star of Hollywood's silver screen-era. Yet even now ...
- Chronic UTIs: ‘I’ve battled crippling infections for three decades, it’s time politicians took this seriously’on May 20, 2022 at 9:33 am
Sarah Heaton, from West Yorkshire and aged in her 30s, has lived with UTIs since she was a child and developed a chronic infection last summer that has left her in pain every day since ...
- New funding boost to combat antibiotic resistanceon May 19, 2022 at 8:42 pm
Antibiotics have saved countless lives since they were introduced in the 1940s, curing infections and making procedures like chemotherapy and surgeries safer. But their effectiveness is waning.
- Can we prevent antibiotic resistance?on May 19, 2022 at 12:53 pm
Boston University has been at the forefront of an international effort to combat antimicrobial resistance (AMR), leading CARB-X, a nonprofit partnership that channels funding and expertise to ...
- Man v. Microbe: Drug-resistant superbugs gain a toehold in Michiganon May 19, 2022 at 11:36 am
The overuse of antibiotics — in ERs, dental offices, and for your steak dinner — means microbes are gaining ground in a microscopic arms race. Next time you ask for antibiotics, your doctor may say ...
- The FDA Just Approved a First-of-Its-Kind Drug for Chronic Yeast Infectionson May 18, 2022 at 2:57 pm
The U.S. Food and Drug Administration (FDA) has approved the first oral antifungal medication, called Vivjoa, to specifically treat recurrent vaginal yeast infections. The administration said in a ...
- Developing innovative approaches to combat urinary tract infectionson May 18, 2022 at 6:56 am
The German government is providing about 2.4 million Euros for a new research group in infectious diseases at JMU Würzburg.
The Latest Google Headlines on:
Drug-resistant and recurrent infections
The Latest Bing News on:
- Most doctors still believe in prescribing unnecessary antibiotics to treat asymptomatic infections, study suggestson May 27, 2022 at 8:35 am
An estimated 70% of primary care physicians reported in a survey that they would still prescribe antibiotics to treat asymptomatic infections based solely on a positive urine specimen. This is despite ...
- Researchers discover bifunctional lipopeptide antibiotic with a low resistance potentialon May 27, 2022 at 7:45 am
Through bioinformatic prospecting, researchers discovered and synthesized a novel, naturally inspired bifunctional lipopeptide antibiotic with a low resistance potential.
- Algorithm-aided antibiotic hunt yields powerful new drug candidateon May 27, 2022 at 1:21 am
Algorithms have helped uncover a new antibiotic candidate that shows promise against some particularly nasty bugs, using a novel mode of attack that should be hard for them to develop resistance to.
- Aston University: New antibiotic combination developed at Aston University helps save life of cystic fibrosis patienton May 26, 2022 at 9:07 pm
A new antibiotic combination developed by researchers at Aston University has formed part of a lifesaving treatment used in the USA. The antibiotic combination of imipenem/relebactam with amoxicillin ...
- Aston University’s new antibiotic combination forms part of a lifesaving treatment for cystic fibrosison May 26, 2022 at 4:53 pm
A new antibiotic combination developed by researchers at Aston University has formed part of a lifesaving treatment used in the USA.
- Washington Univ. study shows inappropriate antibiotics for children lead to health complications, increased costson May 26, 2022 at 4:08 pm
A new study from Washington University in St. Louis says inappropriate antibiotics cause serious medical conditions for children, resulting in at least $74 million in excess health care costs in ...
- Frequent Use of Antibiotics Tied to Inflammatory Bowel Disease in Older Adultson May 26, 2022 at 1:52 pm
Older people who frequently take antibiotics are at greater risk of developing inflammatory bowel disease (IBD) , according to research presented at Digestive Disease Week (DDW) 2022 . The study has ...
- A synthetic antibiotic may help turn the tide against drug-resistant pathogenson May 26, 2022 at 11:00 am
A new antibiotic, synthesized at The Rockefeller University and derived from computer models of bacterial gene products appears to neutralize even drug-resistant bacteria. The compound, named ...
- Antibiotic Resistance: A Looming Public Health Crisison May 25, 2022 at 1:41 pm
Whether through overuse of antibiotics, inadequate infection prevention or natural evolution, bacteria, fungi, and other germs can become impervious to the very drugs meant to kill them. These ...
- New insights into antibiotic resistanceon May 25, 2022 at 7:35 am
Treatment of severe infections caused by pathogenic bacteria relies on ‘last resort’ antibiotics, but rising resistance by ‘superbugs’ to most clinically approved drugs leaves patients exposed to ...